Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: a propensity score adjusted retrospective cohort study

Early treatment of high-risk COVID-19 patients may prevent disease progression. However, there are limited data to support treatment of hospitalized or fully vaccinated patients with mild-to-moderate disease. In this retrospective cohort study, we studied the effect of early use of sotrovimab and re...

Full description

Saved in:
Bibliographic Details
Main Authors: Koh, Lin Pin, Chua, Siang Li, Vasoo, Shawn, Toh, Matthias Paul Han Sim, Cutter, Jeremy Nicholas, Nah, Puay Hoon, Leo, Yee Sin, Tay, Jun Xin, Young, Barnaby Edward, Lye, David C., Ong, Sean W. X.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/172156
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
Be the first to leave a comment!
You must be logged in first